The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl 2-Imino-10-methyl-5-oxo-1-propyl-1,5-dihydro-2H-dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxylate ID: ALA4551928
Cas Number: 500147-68-2
PubChem CID: 706445
Max Phase: Preclinical
Molecular Formula: C18H20N4O3
Molecular Weight: 340.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCn1c(=N)c(C(=O)OCC)cc2c(=O)n3cccc(C)c3nc21
Standard InChI: InChI=1S/C18H20N4O3/c1-4-8-21-14(19)12(18(24)25-5-2)10-13-16(21)20-15-11(3)7-6-9-22(15)17(13)23/h6-7,9-10,19H,4-5,8H2,1-3H3
Standard InChI Key: UCGIHIJBLPQGTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
12.0061 -15.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0061 -15.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7155 -16.3562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7155 -14.7136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4208 -15.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4218 -15.9476 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1303 -16.3572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1282 -14.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8412 -15.1245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8414 -15.9478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5512 -16.3590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2652 -15.9473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2649 -15.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5506 -14.7124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1295 -17.1785 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9770 -14.7159 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9766 -16.3607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9758 -17.1820 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5492 -13.8911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7166 -13.8964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6851 -15.9535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3921 -16.3635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1006 -15.9563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2562 -13.4813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2548 -12.6641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
5 8 2 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
9 14 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
7 15 2 0
13 16 2 0
12 17 1 0
17 18 2 0
14 19 1 0
4 20 1 0
17 21 1 0
21 22 1 0
22 23 1 0
19 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.38Molecular Weight (Monoisotopic): 340.1535AlogP: 2.02#Rotatable Bonds: 4Polar Surface Area: 89.45Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.60CX LogP: 2.03CX LogD: 1.96Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.58Np Likeness Score: -1.40
References 1. Dong Z, Wang Z, Guo ZQ, Gong S, Zhang T, Liu J, Luo C, Jiang H, Yang CG.. (2020) Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer., 63 (9): [PMID:32297747 ] [10.1021/acs.jmedchem.0c00161 ]